If you’ve been dealing with chronic knee pain from osteoarthritis, you’ve probably already tried cortisone injections. They work — for a while. But when the relief fades after a few weeks or months, you’re left wondering: is there something better?
Genicular artery embolization (GAE) is emerging as a promising alternative that may provide longer-lasting relief. Here’s a head-to-head comparison to help you understand your options.
Treatment Comparison
Cortisone Injections: Standard Treatment
VS
GAE: Emerging Treatment
How Each Treatment Works
Cortisone Injections
Cortisone is a powerful anti-inflammatory steroid injected directly into the knee joint. It works by temporarily reducing inflammation and swelling, which decreases pain. The injection takes just minutes and provides relief within days.
However, cortisone doesn’t address the underlying cause of osteoarthritis — it simply masks the symptoms. Research shows that effects typically last 3–6 months at best, and repeated injections may accelerate cartilage damage over time.
Genicular Artery Embolization (GAE)
GAE takes a different approach. Instead of masking inflammation, it targets the source: abnormal blood vessels that grow in the knee lining during osteoarthritis. These new vessels carry inflammatory cells and pain-sensitizing nerves.
During GAE, a vascular specialist guides a tiny catheter to these abnormal vessels and blocks them with microscopic particles. This reduces inflammation at its source and interrupts pain signaling — without affecting healthy tissue or joint structures.
Side-by-Side Comparison
| Factor | Cortisone | GAE |
| Procedure time | 5–10 min | 60–90 min |
| Duration of relief | 3–6 months | 12–24+ months |
| Repeat treatments | Multiple/year | Rarely needed |
| Cartilage effects | May harm cartilage | No cartilage impact |
| Addresses root cause | No | Yes |
| Recovery time | Same day | 2–3 days |
| Evidence of benefit at 2 years | Limited data | 72% sustained |
How Long Does Relief Last?
Typical Duration of Pain Relief by Treatment
Cortisone: 3–6 mo
Hyaluronic Acid: 6–12 mo
PRP: 6–12 mo
GAE: 12–24+ mo
What the Research Shows
99.7% Technical success rate across 270 patients
(Meta-analysis, J Clin Med 2023)
47% Achieved ≥50% pain reduction at 24 months
(UCLA IDE Trial, JVIR 2024)
72% Sustained success among initial responders at 2 years
(UCLA IDE Trial, JVIR 2024)
5.2% Needed knee replacement at 2 years
(UCLA IDE Trial, JVIR 2024)
“Data on 2-year benefit for any localized therapy — intra-articular steroid, hyaluronic acid, or PRP — do not exist. Benefits are typically limited to less than 12 months’ duration. GAE represents a potential paradigm shift in how we approach knee OA treatment.”
— Journal of Vascular and Interventional Radiology, September 2024
Cost-Effectiveness Analysis
4-Year Treatment Cost Comparison
(From U.S. Medicare payer perspective (AJR 2024))
Cortisone Injections: Multiple treatments every 3–6 months
GAE: Most cost-effective in all tested scenarios
RF Ablation: Higher overall cost | Requires nerve block
Study found GAE consistently the most likely cost-effective option over 4 years
Is GAE Right for You?
Quick Candidacy Check
- Knee pain diagnosed as osteoarthritis (KL grade 2–4)
- Tried cortisone or other injections with limited/temporary relief
- Not ready for knee replacement surgery
- Looking for a minimally invasive option
- Pain lasts more than 3 months despite conservative treatment
The MOTION Trial: The Definitive Comparison
A major international randomized controlled trial called MOTION is currently underway, directly comparing GAE with cortisone injections across 45+ centers worldwide. This investigational device exemption (IDE) study will provide the highest level of evidence on how these treatments compare.
The primary endpoint is clinical success at 6 months, defined as 50% or greater improvement in pain scores without needing additional interventions. Results are expected to further clarify who benefits most from each approach.
Making Your Decision
Both cortisone injections and GAE have their place in treating knee osteoarthritis. Cortisone remains a reasonable first-line option for acute flare-ups and short-term relief. But for patients who need something more lasting — or who’ve already cycled through multiple injections — GAE offers a fundamentally different approach.
At Surgical Associates, we offer both treatments and can help you understand which option makes the most sense for your specific situation. The right choice depends on your pain severity, activity level, previous treatments, and long-term goals.
Ready to Explore Longer-Lasting Relief?
If cortisone injections aren’t giving you the relief you need, GAE may be your next step. Schedule a consultation to discuss your options.
📍 Now offering GAE at our Reston, VA office

Dr. Rahbar is an esteemed vascular surgeon at Surgical Associates, known for their exceptional contributions to the field of vascular surgery. As a board-certified vascular surgeon with over 20 years of invaluable experience, Dr. Rahbar is a respected authority in the medical community serving Reston, VA, Maryland & DC. His unwavering dedication to providing advanced care for patients with diseases of the arteries and veins has earned them a reputation for excellence. Dr. Rahbar’s work embodies a passion for precision and compassion, improving the lives of those they serve, one procedure at a time.